Japan to Name 11 Centers for Genome-Based Cancer Treatment (News)
[2018.02.16] Read in: 日本語 | Русский |

Tokyo, Feb. 14 (Jiji Press)—The Ministry of Health plans to designate a total of 11 hospitals across Japan as regional centers for genome-based cancer treatment, it was learned Wednesday.

At a meeting on the day, a panel of experts recommended 11 institutions to the ministry, choosing them from among 23 hospitals that applied for the status by the end of last year.

The 11 centers are expected to find partner hospitals in their respective regions in a month. In April they will begin a project to provide personalized cancer treatment using patients’ genetic information.

The 11 are Hokkaidō University Hospital, Tōhoku University Hospital, the National Cancer Center Hospital, the National Cancer Center Hospital East, the University of Tokyo Hospital, Keiō University Hospital, Nagoya University Hospital, Kyoto University Hospital, Osaka University Hospital, Okayama University Hospital and Kyūshū University Hospital.

The designations as genome-based cancer treatment centers are set to expire in two years. The ministry is considering making the treatment available in more medical facilities after this initial period.

[Copyright The Jiji Press, Ltd.]

  • [2018.02.16]
Related articles
Other columns

Video highlights

New series

  • From our columnists
  • In the news